+91 780-304-0404

Dry Eye Disease Market

Dry Eye Disease Market Size, Share & Trends Analysis Report, By Type (Aqueous and Evaporative), By Treatment (Anti-Inflammatory Drugs, Artificial Tears, Punctal Plug and Secretagogue) and Forecast, 2019-2025
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2020016 | Category : Pharmaceuticals | Delivery Format: /

The global dry eye disease market is estimated to grow at a CAGR of 4.6% during the forecast period. The major factors contributing to the growth of the market include the increasing prevalence of diabetes associated ocular problems, emerging demand for contact lenses and awareness programs for dry eye disease. People suffering from diabetes are prone to diabetic eye conditions including diabetic retinopathy, diabetic macular edema (DME), cataract, glaucoma and other diseases. One of the major causes of these diseases is the change in retinal blood vessels that causes leakage of fluid resulting in vision loss which as a result affect tear film of the eyes to some extent. 

According to the European Society of Retina Specialists (EURETINA), about 25% of diabetic patients are suffering from Diabetic Eye Disease (DED) in European countries. Italy is the highest affected country with 34% followed by the UK (29%). EURETINA has also estimated that in the EU region, there are about 4 million individuals over the age of 40 years suffering from any kind of dry eye disease. Each year, 4.6% of Europeans with diabetes are newly affected by any DED, corresponding to more 770,000 individuals in the EU per year. Hence, a significant prevalence of diabetic eye conditions is one of the major factors for the growing incidences of dry eye disease. 

Segment Outlook

The global dry eye disease market is segmented based on type and treatment. Based on type, the market is classified into aqueous and evaporative. Based on treatment, the market is classified into anti-inflammatory drugs, artificial tears, punctal plug, and secretagogue.

Anti-inflammatory drugs have witnessed a significant share in the treatment segment

Anti-inflammatory drugs are being significantly used for the treatment of dry eye disease. The treatment of dry eye syndrome was limited to the use of artificial tears, ointments, and therapies, including punctal occlusion, moisture-retaining eyewear, environmental control, and surgery. Some patients may suffer from eye irritation in spite of sufficient aqueous enhancement therapies without anti-inflammatory drugs. Therefore, anti-inflammatory drugs may be considered along with aqueous enhancement therapies. This, in turn, results in the emerging demand for anti-inflammatory agents for the treatment of dry eye syndrome. 

Clinical evidence specifies that anti-inflammatory therapy hinders the production of inflammatory mediators and minimizes the signs and symptoms of dry eye disease. Corticosteroids are considered as potent anti-inflammatory agents that can effectively and rapidly relieve the signs and symptoms of severe dry eye. Corticosteroids have been witnessed to reduce symptoms of ocular irritation and fluorescein staining of the cornea and improve filamentary keratitis. 

Global Dry Eye Disease Market Share by Treatment, 2018 (%)

Global Dry Eye Disease Market Share by Treatment

Regional Outlook

Based on geography, the global dry eye disease market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America has witnessed potential growth in the market owing to the rising use of contact lenses and significant awareness for dry eye disease.  According to the Centers for Disease Control & Prevention (CDC), in 2016, an estimated 45 million Americans used contact lenses, of which 14.5% of adolescents were 17 years or younger wore contact lenses. In 2016, an estimated 3.6 million (14.5%) adolescents and 7.5 million (24.4%) young adults aged 18-24 wore contact lenses. In addition, an estimated 33.9 million adults (15.5%) aged 25 and over worn contact lenses in 2016. Contact lenses may result in irritation on the eye surface and affect tear film which as a result increases the need for artificial tears.

Global Dry Eye Disease Market Growth by Region, 2019-2025

Global Dry Eye Disease Market Growth by Region

Asia-Pacific is estimated to witness considerable growth in the market during the forecast period

Asia-Pacific dry eye disease market is estimated to witness considerable growth in the market during the forecast period owing to a rapidly growing aging population, and rising air pollution, which is also one of the major factors affecting the ocular surface that leads to irritation and dry-eye disease. The rising burden of an aging population is a major risk factor that increases the chances of having dry-eye disorder among the older population. Additionally, the Chinese government's support for the treatment of ophthalmic diseases is also expected to influence market growth. In 2016, China had adopted a 13th 5-year national plan for eye health (2016-2020). Under this plan, the supporting measures are taken at all levels by Health and Family Planning Commissions that are focused on putting significant attention to eye disease treatment and prevention.

In addition, it involves promoting eye health awareness and set up a favorable environment for eye care. 90% of the counties have medical care institutes of eye health and of which 90% can perform cataract procedure. This plan is focused on appointing new personnel for the treatment of eye diseases. Such government initiatives may lead to encourage healthcare infrastructure for eye treatment, which in turn, is expected to fuel the adoption of treatment options for dry eye diseases.

Market Players Outlook

The major players in the market include Novartis AG, Allegan PLC, Johnson & Johnson Vision Care, Inc., Santen Pharmaceutical Co., Ltd., and Bausch Health Companies, Inc. Geographical expansion, mergers and acquisitions, product launches and partnerships and collaborations are considered as crucial strategies adopted by the companies to expand their market share and gain a competitive advantage over other competitors. For instance, in October 2019, Sun Pharmaceutical Industries Ltd. declared that one of its wholly owned subsidiaries has commercialized CEQUA (cyclosporine ophthalmic solution) 0.09% in the US. CEQUA approved by the US FDA is aimed at increasing tear production in dry eye patients. CEQUA is the first and only FDA-approved cyclosporine treatment that is delivered with nanomicellar (NCELL) technology. This will enable to improve the bioavailability and physicochemical stability of cyclosporine, which leads to improved ocular tissue penetration.

The Report Covers

  • Market value data analysis of 2018 and forecast to 2025.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global dry eye disease market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Novartis AG

3.3.1.1. Overview

3.3.1.2. Financial Analysis

3.3.1.3. SWOT Analysis

3.3.1.4. Recent Developments

3.3.2. Allergan PLC

3.3.2.1. Overview

3.3.2.2. Financial Analysis

3.3.2.3. SWOT Analysis

3.3.2.4. Recent Developments

3.3.3. Johnson & Johnson Vision Care, Inc.

3.3.3.1. Overview

3.3.3.2. Financial Analysis

3.3.3.3. SWOT Analysis

3.3.3.4. Recent Developments

3.3.4. Santen Pharmaceutical Co., Ltd.

3.3.4.1. Overview

3.3.4.2. Financial Analysis

3.3.4.3. SWOT Analysis

3.3.4.4. Recent Developments

3.3.5. Bausch Health Companies, Inc.

3.3.5.1. Overview

3.3.5.2. Financial Analysis

3.3.5.3. SWOT Analysis

3.3.5.4. Recent Developments

4. Market Determinants 

4.1 Motivators

4.2 Restraints

4.3 Opportunities 

5. Market Segmentation

5.1. Global Dry Eye Disease Market by Type

5.1.1. Aqueous 

5.1.2. Evaporative

5.2. Global Dry Eye Disease Market by Treatment

5.2.1. Anti-Inflammatory Drugs

5.2.1.1. Lifitegrast

5.2.1.2. Corticosteroid

5.2.1.3. Cyclosporine

5.2.2. Artificial Tears

5.2.3. Punctal Plug

5.2.4. Secretagogue

6. Regional Analysis

6.1. North America

6.1.1. United States

6.1.2. Canada

6.2. Europe

6.2.1. UK

6.2.2. Germany

6.2.3. Italy

6.2.4. Spain

6.2.5. France

6.2.6. Rest of Europe 

6.3. Asia-Pacific

6.3.1. China

6.3.2. India

6.3.3. Japan

6.3.4. Rest of Asia-Pacific 

6.4. Rest of the World

7. Company Profiles

7.1. AFT Pharmaceuticals

7.2. Akorn, Inc. (Fresenius SE & Co. KGaA)

7.3. Allergan PLC

7.4. Bausch Health Companies, Inc.

7.5. Beaver-Visitec International Holdings, Inc. 

7.6. FCI Ophthalmics

7.7. I-MED Pharma, Inc.

7.8. Johnson & Johnson Vision Care, Inc.

7.9. Medennium, Inc.

7.10. Novaliq GmbH

7.11. Novartis AG

7.12. OASIS Medical, Inc.

7.13. Otsuka Pharmaceutical Co., Ltd.

7.14. Pfizer, Inc.

7.15. Rohto Pharmaceutical Co., Ltd.

7.16. Santen Pharmaceutical Co., Ltd.

7.17. Scope Ophthalmics, Ltd.

7.18. Sentiss Pharma Pvt. Ltd.

7.19. Sun Pharmaceutical Industries, Ltd.

7.20. URSAPHARM Arzneimittel GmbH

7.21. VISUfarma

1. GLOBAL DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

2. GLOBAL AQUEOUS DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

3. GLOBAL EVAPORATIVE DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

4. GLOBAL DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

5. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

6. GLOBAL ARTIFICIAL TEARS FOR DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

7. GLOBAL PUNCTAL PLUG FOR DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

8. GLOBAL SECRETAGOGUE FOR DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

9. GLOBAL DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

10. NORTH AMERICAN DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

11. NORTH AMERICAN DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

12. NORTH AMERICAN DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

13. EUROPEAN DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

14. EUROPEAN DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

15. EUROPEAN DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

16. ASIA-PACIFIC DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

17. ASIA-PACIFIC DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

18. ASIA-PACIFIC DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

19. REST OF THE WORLD DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

20. REST OF THE WORLD DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

1. GLOBAL DRY EYE DISEASE MARKET SHARE BY TYPE, 2018 VS 2025 (%)

2. GLOBAL DRY EYE DISEASE MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)

3. GLOBAL DRY EYE DISEASE MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

4. US DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

5. CANADA DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

6. UK DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

7. FRANCE DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

8. GERMANY DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

9. ITALY DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

10. SPAIN DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

11. ROE DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

12. INDIA DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

13. CHINA DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

14. JAPAN DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

15. REST OF ASIA-PACIFIC DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

16. REST OF THE WORLD DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)

Choose License Type
    On Discount

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports